Press Releases

Register now to see a June 11, 1 pm Eastern discussion featuring Milken Institute's Holly Freishtat and NACDS' Steven C. Anderson - who will elaborate on a major announcement planned for that date.

Analysis Will Study Effects of IRA Provisions to Improve Access to Basal Insulin

Almost half of independent pharmacy owners/managers participating in an NCPA survey said that ESI was the pharmacy benefit manager causing the most financial stress in Medicare Part D.

Courtney B. Smith, PharmD, CSP, BCMTMS has been awarded a prestigious 2024 NASPA Excellence in Innovation Award.

As part of the Dr. Reddy’s senior leadership team, he will be responsible for the company’s North America business and will be based out of the Princeton, New Jersey, U.S. office.

Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK)

Rufinamide Oral Suspension is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in pediatric patients 1 year of age and older, and in adults.

Pagniano’s responsibilities will include leading the foundation’s strategic growth.

Camber Pharmaceuticals is thrilled to announce the addition of Aripiprazole Oral Solution to its product line, complementing the existing product family that included Aripiprazole Tablets.

The partnership aims to accelerate innovation in drug discovery by increasing success rates and reducing timelines through screening a billion+ small-molecule compounds either in a living cell or on a purified drug target protein.

In September 2022, Bayer launched the patented drug vericiguat under the brand name Verquvo™ in India.

Camber Pharmaceuticals is pleased to announce the addition of Levonorgestrel and Ethinyl Estradiol Tablets USP to its current portfolio.

Aurigene.AI is an end-to-end solution for small molecule drug discovery combining AI and ML capabilities with Aurigene's core expertise in synthesizing and testing the molecules in vitro and in vivo.

Camber Pharmaceuticals is pleased to announce the addition of Allopurinol Tablets, USP to its current portfolio.

Alabama Pharmacist Recognized for Advancing the Profession of Pharmacy

Theophylline Extended-Release Tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases.

Versavo® (bevacizumab) is indicated for the treatment of several types of cancers including metastatic colorectal cancer, advanced non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, advanced cervical cancer, ovarian cancer and metastatic breast cancer.

Gabapentin Tablets (generic for Gralise®) are indicated for the management of Postherpetic Neuralgia (PHN).

Registration open for McKesson ideaShare, premier community pharmacy education and networking event

Camber Pharmaceuticals is pleased to announce the addition of Icoapent Ethyl Capsules to its current portfolio.

NCPA members highlighted during White House roundtable on PBMs and virtual town hall on monopoly power.

The National Community Pharmacists Association issued a statement on behalf of CEO B. Douglas Hoey.

Oxcarbazepine Oral Suspension, USP 300 mg/5 mL is available in 250 mL bottles.

Point-of-care testing services enhance patient care, support pharmacy revenue